Our Organisation2024-05-02T10:18:59+00:00

Our Organisation

The CRUK City of London Centre partners are UCL, Barts/QMUL, King’s Health Partners and the Francis Crick Institute. The CRUK City of London Centre is run by an Executive Board, who determine the strategy and budget allocations across the Centre. The committee is composed of representatives from each partner institution. The day-to-day operations of the Centre are carried out by a management team based in the UCL Cancer Institute.

The shared Major Centre vision is built on the commitment and engagement of the partners, their host Institutions, and the associated NHS Trusts. These are brought together at the highest level through the Major Centre’s Oversight Committee, comprising senior institutional representatives with an independent Chair. The CRUK CoL Centre is funded by Cancer Research UK.

Executive Board 

The Executive Board is chaired by the Centre Lead Prof. Tariq Enver. Its remit is to drive the Centre strategy and to manage resources. Each Institution is represented by two members. The EB will also have an EDI lead and a Patient Advocate, and liaises with the partner Trusts through the AHSCs via established liaison committees.

The CRUK City of London Centre is a Global Centre and this is reflected both in the diversity of our Centre staff and the population we serve through our Academic Health Centres. It is imperative that our research community and our leadership structures reflect this, thereby ensuring inclusivity and the excellence that only diversity can bring. We are currently reviewing our diversity metrics and committees with a view to continuous improvement in EDI.

  • Prof Tariq Enver – City of London (CoL) Centre Lead, Director of the UCL Cancer Institute
  • Prof Nitzan Rosenfeld – Director of Barts Cancer Institute, QMUL
  • Prof Anita Grigoriadis – CoL Centre Discovery Training Lead, KCL
  • Prof Richard Treisman – CoL Centre Core Facilities Lead, Research Director, Francis Crick Institute
  • Prof Charles Swanton – CoL Centre Industry Lead, CRUK UCL-Crick Clinical Cancer Medicine Lead, Francis Crick Institute
  • Prof Kairbaan Hodivala-Dilke – CoL Centre Theme Lead, Barts Cancer Institute, QMUL
  • Prof Karin Straathof – CoL Centre Theme Lead, UCL Great Ormond Street Institute of Child Health
  • Dr Mariam Jamal-Hanjani – CoL Centre EDI Lead, UCL Cancer Institute
  • Prof James Spicer – Professor of Experimental Cancer Medicine, KCL
  • Prof Gert Attard – CoL Centre Clinical Training Lead, UCL Cancer Institute
  • Prof Erik Sahai – CoL Centre Events Lead, Francis Crick Institute

Leadership for the Centre is provided by the Centre Co-Directors in close collaboration with the Centre Senior Project Manager, Dr Feng Li, who is also responsible for coordinating and implementing Centre activity.

The CRUK CoL Centre’s Core Management team are located in the UCL Cancer Institute in the Paul O’Gorman Building, Room 127.


  • Prof Frances Balkwill, OBE FMedSci – Professor of Cancer Biology, Barts Cancer Institute, QMUL and City of London (CoL) Centre Theme 1 Lead and CoL Centre PPIE Committee Chair.
  • Ambi Williams – Research Manager at Kings Health Partners Comprehensive Cancer Centre
  • Araya Gautam: Cancer patient/carer representative
  • David Chuter: Cancer patient/carer representative
  • Dr Feng Li – CoL Centre Senior Project Manager, UCL Cancer Institute
  • Hafiza Bibi – CRUK RadNet Project Manager, UCL Cancer Institute
  • Dr Iris Lüke, – CoL Centre Postgraduate Manager, Francis Crick Institute
  • Prof John Marshall – Professor of Tumour Biology, Barts Cancer Institute, QMUL
  • Dr Maria Lioumi – Strategic Research and Development Manager, KCL
  • Dr Nnenna Kanu – Principal Research Fellow, UCL Cancer Institute
  • Veronica Dominguez – CoL Centre coordinator, UCL Cancer Institute

The Scientific Advisory Board is external to the CRUK CoL Centre and provides advice to the Executive Management Board.

  • Professor Anton Berns (Chair) – Former Research Director of the Netherlands Cancer Institute (NKI)
  • Dr John Shields – Director at JGSbiopharma Ltd
  • Professor Stephanie Combs – Professor and Chair of the Department of Radiation Oncology at the Technical University of Munich (TUM), Germany
  • Professor George Iliakis – Head of Experimental Radiation Biology at University Hospital Essen, Germany
  • Professor Valerie M. Weaver – Professor & Director, Center for Bioengineering and Tissue Regeneration & Co-Director Bay Area Center for Physical Sciences and Oncology, University of California San Francisco
  • Professor Brenda Andrews – Professor of Molecular Genetics and Director of the Donnelly Centre for Cellular and Biomolecular Research at the University of Toronto
  • Professor Karen Brown – Professor in Translational Cancer Research, Leicester Cancer Research Centre, University of Leicester
  • Professor Josef Vormoor – Paediatric Oncologist in the Princess Máxima Center, Utrecht, Netherlands
  • Dr Anne-Marie Martin – Senior Vice President, Global Head of Experimental Medicine at GlaxoSmithKline
  • Rabbi The Baroness Neuberger (Chair)- British member of the House of Lords
  • Dr Sam Barrell, Deputy Chief Executive Officer, The Francis Crick Institute
  • Professor Sir Richard Trembath, Vice-Principal (Health), Executive Director of King’s Health Partners
  • Prof Joanne Martin, Deputy Vice Principal Health, Queen Mary University of London
  • Prof Ibrahim Abubakar, Pro-Provost (Health), University College London
  • Senior CRUK Representative